Clovis Oncology (CLVS) Welcomes Two New Directors to its Board
6/14/2013 7:00:46 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Clovis Oncology, Inc. (Nasdaq: CLVS), announced today the addition of two new members to its Board of Directors, Ginger Graham and Keith Flaherty, M.D.
“We are delighted to add these two gifted individuals to our Board of Directors as the Company matures into a later-stage developer of oncology products and ultimately a commercial organization,” said Patrick J. Mahaffy, president and CEO of Clovis Oncology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by